Caroline C Sigman

Considerations in the development of circulating tumor cell technology for clinical use

Massimo Cristofanilli, Klaus Pantel, David R Parkinson, 2012, Journal of Translational Medicine.

A QA Program for MRD Testing Demonstrates That Systematic Education Can Reduce Discordance Among Experienced Interpreters

Gary Kelloff, Gerard Lozanski, Brent L Wood, 2018, Cytometry. Part B, Clinical cytometry.

Imaging and oncologic drug development.

Wafik S El-Deiry, W. El-Deiry, C. Sigman, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development

Bruce D Cheson, David A Mankoff, Daniel C Sullivan, 2005, Clinical Cancer Research.

New science-based endpoints to accelerate oncology drug development.

C. Sigman, G. Kelloff, Caroline C Sigman, 2005, European journal of cancer.

Lung Master Protocol (Lung-MAP)—A Biomarker-Driven Protocol for Accelerating Development of Therapies for Squamous Cell Lung Cancer: SWOG S1400

David Wholley, Jeffrey D Bradley, Dana Sparks, 2015, Clinical Cancer Research.